DBV Technologies S.A. (DBVT) Stock Plunged 21.71% Pre-Market, Here’s Why
DBV Technologies S.A. (DBVT) stock plummeted 21.71% in the pre-market trading session at the price of $1.37 after reporting its earnings report for the full year 2021. DBVT is producing Viaskin, proprietary technology with extended applications in immunotherapy. Viaskin operates on EPIT to develop biologically